Canada Facial Injectable Market Size & Outlook, 2023-2030
Canada facial injectable market, 2018-2030 (US$M)
Related Markets
Canada facial injectable market highlights
- The Canada facial injectable market generated a revenue of USD 159.2 million in 2023 and is expected to reach USD 276.7 million by 2030.
- The Canada market is expected to grow at a CAGR of 8.2% from 2024 to 2030.
- In terms of segment, botulinum toxin type a was the largest revenue generating product in 2023.
- HA is the most lucrative product segment registering the fastest growth during the forecast period.
Facial injectable market data book summary
| Market revenue in 2023 | USD 159.2 million |
| Market revenue in 2030 | USD 276.7 million |
| Growth rate | 8.2% (CAGR from 2023 to 2030) |
| Largest segment | Botulinum toxin type a |
| Fastest growing segment | HA |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Collagen, Botulinum Toxin Type A, HA, CaHA, Polymer Fillers |
| Key market players worldwide | Ipsen SA, AbbVie Inc, Medytox, Revance Therapeutics Inc, Galderma Group AG Registered Shares, Sinclair Pharma plc, Merz Pharma |
Other key industry trends
- In terms of revenue, Canada accounted for 1.3% of the global facial injectable market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In North America, U.S. facial injectable market is projected to lead the regional market in terms of revenue in 2030.
- U.S. is the fastest growing regional market in North America and is projected to reach USD 8,913.6 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Facial Injectable Market Scope
Facial Injectable Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Canada facial injectable market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to facial injectable market will help companies and investors design strategic landscapes.
Botulinum toxin type a was the largest segment with a revenue share of 55.53% in 2023. Horizon Databook has segmented the Canada facial injectable market based on collagen, botulinum toxin type a, ha, caha, polymer fillers covering the revenue growth of each sub-segment from 2018 to 2030.
Canada’s facial injectables market is driven by the growing number of players entering into strategic partnerships and novel product launches. For instance, in June 2023, Galderma launched Restylane Eyelight in Canada.
The product aims to correct infraorbital hollowing. Moreover, clinical evidence of the efficacy of the product is expected to propel its adoption across regions. According to the same source, 84% of the patients who received the product stated, “pleased with the result,” while nearly 94% of the patients stated that they would recommend the product to an acquaintance.
Furthermore, in January 2021, Crescita Therapeutics, Inc. submitted an application to the Canadian medical regulatory agency, Health Canada for its product range, ART-FILLER injectables. The product range includes five HA-based dermal fillers.
Reasons to subscribe to Canada facial injectable market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Canada facial injectable market databook
-
Our clientele includes a mix of facial injectable market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Canada facial injectable market , including forecasts for subscribers. This country databook contains high-level insights into Canada facial injectable market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Canada facial injectable market size, by product, 2018-2030 (US$M)
Canada Facial Injectable Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related regional statistics
No records
No related regions found.
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
